Market Place
Sourcing Support
All News #Library
Generics
Shire CEO Flemming Ornskov is hatching a few new stretch goals for R&D in 2018
11 Jan 2018 //
ENDPTS
Shire’s experimental HAE drug hits phase 3 marks
11 Sep 2017 //
FIERCE BIOTECH
A decade behind schedule, Shire finally gets an FDA OK for long-acting ADHD drug
21 Jun 2017 //
ENDPTS
Advate (Factor IX): Baxalta V. Genentech, Inc. & Chugai Pharmaceutical
04 May 2017 //
PATENT LITIGATION
Gattex (Teduglutide): Shire-NPS Pharma v. AmbioPharm & Par Pharmaceutical
10 Apr 2017 //
PATENT LITIGATION
Prasco Expands Its Portfolio Through Acquisition of Teva`s Authorized Generic
29 Jun 2016 //
PR NEWSWIRE
Pharma`s new patent worry by the numbers: No `IP death squad` here, analyst says
04 Sep 2015 //
FIERCE PHARMA
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.